Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Stock
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
-1.6M
-
Total reported value, excl. options
-
$41.3M
-
Value change
-
-$3.1M
-
Put/Call ratio
-
0
-
Number of buys
-
19
-
Number of sells
-
-27
-
Price
-
$2.24
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q3 2021
64 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q3 2021.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
.
Largest 10 shareholders include BVF INC/IL (4.78M shares), Omega Fund Management, LLC (2.01M shares), VANGUARD GROUP INC (1.99M shares), ALETHEA CAPITAL MANAGEMENT, LLC (1.17M shares), 5AM Venture Management, LLC (1.13M shares), RENAISSANCE TECHNOLOGIES LLC (1.12M shares), Stonepine Capital Management, LLC (783K shares), JACOBS LEVY EQUITY MANAGEMENT, INC (595K shares), ACADIAN ASSET MANAGEMENT LLC (587K shares), and TWO SIGMA ADVISERS, LP (469K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.